Cuba vs Fiji: Tuberculosis patients living with HIV receiving antiretroviral therapy
Cuba
27 patients
in 2021
Fiji
28 patients
in 2021
Cuba rank
96th
Fiji rank
95th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Cuba
- Fiji
How they compare
Fiji currently reports 28 patients against 27 patients in Cuba, a difference of 1 patients.
The two have swapped places 1 time across 17 shared years of data; in 2003 it was Cuba ahead.
Cuba ranks 96th and Fiji ranks 95th of 183 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16 patients | 0.4 patients | 15.6 patients | Cuba |
| 2010s | 62.5 patients | 8.5 patients | 54 patients | Cuba |
| 2020s | 39.5 patients | 22.5 patients | 17 patients | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Cuba or Fiji?
- Fiji, at 28 patients against 27 patients in Cuba as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Cuba and Fiji?
- 1 patients, with Fiji ahead.
- How many years of comparable data are there for Cuba and Fiji?
- 17 years are reported by both, from 2003 to 2021.
- How do Cuba and Fiji rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Cuba ranks 96th and Fiji ranks 95th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.